By Minal Bopaiah, Communications Manager, PSI Recently, the Sustainable Development Solutions Network released the World Happiness Report 2015 – the third in the organization’s annual series. While the field of happiness research is relatively new, it’s increasingly being “considered a proper measure of social progress and goal of public policy,” according to the report’s authors,Read More ›
Unlike the empathy that characterizes the reaction to a natural disaster like a hurricane or earthquake, the public response to Ebola has been driven by fear. The result has been a lack of support for much-needed relief efforts. Companies are joining NGOs, philanthropic partners and public sector leaders to change that. “I don’t know that I’veRead More ›
Q&A with Duncan Blair, Director of Public Health Initiatives, Alere, Inc.
Impact: How do you define innovation? What do you think are some of the most important factors driving innovation in global health?
Read More ›
DB: Innovation is not only about delivering something new but also about delivering something which provides positive outcomes. What you need for innovation really is creative and engaged people — it’s all about people being willing to challenge the status quo. If everybody always thinks the same things, talks the same language and simply tows the party line then that’s not an environment very conducive to innovation. So what you need is people and an environment that fosters and encourages group members to take risks, whether this is an R&D team, a marketing team, a program implementation team, or a policy development team. Without people who are willing to state their opinion and argue their position then you have no innovation.
Q&A with Klaus Brill, Head of Corporate Commercial Relations, Bayer.
Impact: How does Bayer determine a best investment in terms of value, business plan, audience and opportunity?
Read More ›
Klaus Brill (KB): At Bayer, we look for win-win investment opportunities coming to us through various organizations, governments or internal parties. For Bayer, we make sure that the opportunity matches our general interests in terms of our motto “Science for a Better Life.” We do an assessment to ensure that the opportunity matches one of our global core businesses: women’s health care, primary care, oncology, cardiology, and ophthalmology. If we can identify an interest from a business perspective, we can see the opportunity as a win-win investment for us and our partner.
It is imperative that both the public and private sectors work together. Businesses have invested in GAVI because they know that one of the strongest ways to promote global health is through immunization. And quite simply, vaccines provide a strong return on investment. Through collaboration between the public and private sectors, GAVI has been able to raise additional funds and, most importantly, bring significant private-sector expertise, skills, advocacy and visibility to its workRead More ›
Impact interviews Dr. Naveen Rao, lead of Merck for Mothers. In 2011, Merck, known as MSD outside the United States and Canada, created Merck for Mothers, a 10-year, $500 million initiative to reduce maternal mortality globally. Rao shares his thoughts on public-private partnerships and the importance of engaging local partners in efforts to improve maternal health.Read More ›
Through providing increased access to safe water treatment products and promoting hand-washing with soap at critical times, the partnership between Procter & Gamble, USAID, and PSI seeks to prevent diarrhea among approximately 70,000 children under five in Myanmar, thereby reducing the number of preventable deaths. Diarrhea is the second major cause of death among children under five, following pneumonia, which can also be reduced significantly by improving hand-washing practices.Read More ›
By Seth Berkley, CEO of the GAVI Alliance If countries are healthier and more prosperous, then we all benefit. After all, global health means economic health. This is one reason why many governments in wealthier countries have helped fund disease prevention in developing countries, far outside their borders. It’s the right thing to do, butRead More ›
Ask Dr. Arun Gupta, a pediatrician based in the New Delhi area, what makes a sound investment in global health, and his answer may surprise you. Regional coordinator of the International Baby Food Action Network in Asia, Dr. Gupta is now a member of the Prime Minister’s National Council on India’s Nutrition Challenges and chairsRead More ›
With nearly 170 participants registered, 21 countries represented, countless organizations and specialties and the loud buzz of excited conversation, the first ever Unclogging the Blockages in Sanitation workshop in Kampala got off to a great start. Day 1’s goal was to Understand the Blockages: an entire day dedicated to informing participants of the challenges faced within the sanitation sector.Read More ›
When Dr. Rajiv Shah, Administrator of USAID, the world’s largest development agency, flew to Arkansas in September to solidify a new global partnership with Walmart, the world’s largest retailer, the high water mark of a long-developing trend had finally been reached. Public-private partnerships have forever changed the face of development. USAID and Walmart have workedRead More ›